N,N-dimethyltryptamine and related psychedelics and uses thereof
US11866408B2 · kind B2 · utility
0Cited by
3References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 23, 2023 |
| Grant date | Jan 9, 2024 |
| Priority date | — |
| Expiry date | Feb 23, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/657154
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Described herein are compounds that are derivatives of DMT or 5-MeO-DMT and can be metabolically converted to N,N-dimethyltryptamine or analogs thereof upon administration to a subject. In certain embodiments, the compounds described herein are useful for the treatment of conditions associated with a neurological disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.